Sunday, 22 December 2024
  
Login

Australia's most trusted
source of pharma news

Sunday, 22 December 2024
News

Drug in 'jaw-dropping' PBS fail

 Posted 14 May 2024 AM

The public spotlight has been thrown on Australia's ailing PBS scheme with a scathing newspaper article published last weekend highlighting the injustice of medical access - using MSD's top-selling cancer drug, Keytruda, as a prime example.

The News Corp story pulled no punches, describing "a major failure of our health system which lags the world in funding lifesaving treatments" by comparing access between two patients with cancer caused by the same gene fault.

To see the whole article, please login


Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.